Vyome Holdings, Inc
HINDNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $319,714 | $8.0M | $8.7M | $11.2M | $13.6M | $11.3M |
| Operating income | −$10.5M | −$7.7M | −$15.4M | −$46.4M | −$5.9M | −$12.5M |
| Net income | −$10.3M | −$7.1M | −$11.4M | −$46.2M | −$8.8M | −$21.6M |
| Total assets | $6.5M | $4.8M | $10.7M | $11.1M | $120.0M | $37.1M |
| Total liabilities | $2.7M | $5.0M | $4.0M | $7.5M | $8.2M | $22.6M |
| Equity | $3.8M | −$253,000 | $6.7M | $3.7M | $44.3M | $14.5M |
| EPS (diluted) | $-4.86 | $-13.83 | $-110.87 | $-108.90 | $-61.88 | $-5.54 |
| Shares out. | 11.3M | 23.5M | 2.6M | 18.6M | 10.0M | 7.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −3269.4%
- Net margin
- −3209.7%
- Return on equity
- −272.8%
- Return on assets
- −157.9%
- Return on capital (ROCE)
- −277.8%
- Liabilities / assets
- 42.1%
- Debt / equity
- 0.73×
- Book value / share
- $0.33
- Revenue growth (YoY)
- −96.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -50.57distress
- Accruals / assets
- −100.2%clean
- Beneish M-Score
- -18.49normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2022
- NT 10-Qmissed a reporting deadline ↗May 13, 2022
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Cvi Investments, Inc.Passive (13G)Aug 14, 2025
- L1 Capital Global Opportunities Master Fund, Ltd.Passive (13G)Aug 14, 2025
- Ayrton Capital LlcPassive (13G)Aug 13, 2025
- Dominion Capital LlcActivist (13D)Apr 4, 2025
- Leonite Fund I, LpPassive (13G)Feb 24, 2025
- Firstfire Global Opportunities Fund LlcPassive (13G)Feb 24, 2025
- Bigger Capital Fund L PPassive (13G)Feb 21, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 123,132 | 2.6 | +1.4% |
| Apr 30, 2026 | 121,483 | 5.2 | -15.6% |
| Apr 15, 2026 | 143,901 | 8.8 | -9.2% |
| Mar 31, 2026 | 158,474 | 4.9 | +23.3% |
| Mar 13, 2026 | 128,513 | 2.5 | -38.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 29, 2026
- Amended charter or bylaws · Shareholder voteApr 29, 2026
- Entered a material agreement · Other material eventFeb 25, 2026
- Regulation FD disclosureFeb 13, 2026
- Regulation FD disclosure · Other material eventJan 28, 2026
- Entered a material agreementDec 23, 2025
- Results of operationsNov 19, 2025
- Shareholder voteOct 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KCURRENT REPORTMay 29, 2026
- 10-QQUARTERLY REPORTMay 12, 2026
- 8-KCURRENT REPORTApr 29, 2026
- DEF 14APROXY STATEMENTMar 31, 2026
- PRE 14APRELIMINARY PROXY STATEMENTMar 20, 2026
- 10-KANNUAL REPORTMar 18, 2026
- 8-KCURRENT REPORTFeb 25, 2026
- 8-KCURRENT REPORTFeb 13, 2026
- 8-KCURRENT REPORTJan 28, 2026
- 8-KCURRENT REPORTDec 23, 2025
- 424B3PROSPECTUSNov 26, 2025
- 8-KCURRENT REPORTNov 19, 2025
- 4OWNERSHIP DOCUMENTNov 19, 2025
- 3OWNERSHIP DOCUMENTNov 19, 2025
- 4OWNERSHIP DOCUMENTNov 18, 2025